D. Healy

发表

Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.

H. Ke, H. Simmons, T. A. Brown, 2006, Bone.

Short-term immobilization-induced cancellous bone loss is limited to regions undergoing high turnover and/or modeling in mature rats.

R. Lindsay, D. Dempster, V. Shen, 1997, Bone.

Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonists.

Daniel P. Walker, A. Kalgutkar, Joel Morris, 2009, Bioorganic & medicinal chemistry letters.

Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1α.

P. McEwan, Yeon-Hee Lim, A. Cheng, 2022, Journal of medicinal chemistry.

Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis.

B. Maček, S. Vukicevic, V. Paralkar, 2011, Journal of the American Society of Nephrology : JASN.

A Novel, Non‐Prostanoid EP2 Receptor‐Selective Prostaglandin E2 Agonist Stimulates Local Bone Formation and Enhances Fracture Healing

V. Paralkar, B. Lefker, H. Ke, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Parathyroid Hormone-Calcium Homeostasis in Rats and Humans

Anson K. Abraham, T. Maurer, D. Mager, 2009, Journal of Pharmacology and Experimental Therapeutics.

Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.

W. Jee, D. Thompson, V. Shen, 2004, Journal of musculoskeletal & neuronal interactions.

Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.

D. Thompson, H. Ke, H. Simmons, 2005, Bone.

The discovery of novel calcium sensing receptor negative allosteric modulators.

J. Bauman, David A. Price, A. Kalgutkar, 2009, Bioorganic & medicinal chemistry letters.

Alfacalcidol restores cancellous bone in ovariectomized rats.

D. Thompson, H. Ke, H. Simmons, 2003, Journal of musculoskeletal & neuronal interactions.

Human USP18 protects diverse cancer lineages from Type I Interferon independently of its canonical catalytic function

P. Loria, V. Frattini, B. Kessler, 2023, bioRxiv.

A comparison of the anabolic effects of rat and bovine parathyroid hormone (1-34) in ovariectomized rats.

D. Thompson, H. Ke, T. Owen, 2001, Journal of musculoskeletal & neuronal interactions.

Pharmacodynamic Model of Parathyroid Hormone Modulation by a Negative Allosteric Modulator of the Calcium-Sensing Receptor

Anson K. Abraham, A. Kalgutkar, T. Maurer, 2011, The AAPS Journal.

Surface-specific effects of a PPARγ agonist, darglitazone, on bone in mice

H. Ke, H. Simmons, T. A. Brown, 2006 .

Metabolism-guided design of short-acting calcium-sensing receptor antagonists.

J. Bauman, David A. Price, A. Kalgutkar, 2010, ACS medicinal chemistry letters.

A novel role of bone morphogenetic protein-6 (BMP-6) as an endocrine regulator of bone and glucose homeostasis

S. Vukicevic, V. Paralkar, C. Lubeski, 2010 .

The discovery of novel calcium sensing receptor negative allosteric modulators.

J. Bauman, A. Kalgutkar, V. Paralkar, 2009, Bioorganic & medicinal chemistry letters.